Related Experiment Videos
[Pregnancy and inflammatory bowel disease].
1Ammerland Klinik Westerstede, Departamentul de Obstetrică şi Ginecologie.
Summary
Women with inflammatory bowel disease (IBD) can have safe pregnancies if the condition is inactive. Active IBD increases risks for both mother and baby, emphasizing disease control for better outcomes.
Area of Science:
- Gastroenterology and Obstetrics
- Reproductive Health in Chronic Illness
Context:
- Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, frequently impacts women during their childbearing years.
- Pregnancy in women with IBD raises critical questions regarding disease management, maternal health, fetal development, and potential genetic inheritance.
Purpose:
- To explore the intricate relationship between pregnancy and inflammatory bowel disease (IBD).
- To assess the impact of IBD activity on pregnancy outcomes and fetal health.
- To review the safety of IBD medications during pregnancy.
Summary:
- Inactive IBD does not increase adverse fetal outcomes; however, active disease correlates with a higher risk of premature birth.
- Women with active IBD at conception often experience persistent or worsening disease throughout pregnancy.
- The majority of IBD medications are considered safe for use during pregnancy, though exceptions exist.
Impact:
- Highlights that active IBD, rather than its treatment, represents the primary risk factor for adverse pregnancy outcomes.
- Informs clinical management strategies for pregnant women with IBD, prioritizing disease remission.
- Provides crucial information for women with IBD planning pregnancy and their healthcare providers.